Stemtech Corp (STEK) shareholders
STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $296.22KP/E –Yield –
Ownership
Who owns Stemtech's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Benjamin Nathaniel Kaplan | Director | 2,134,094 | 0.07% | Jun 27, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Benjamin Nathaniel Kaplan Director | Jun 23, 2025 | Sale | −1,000,000 | $0.03 | $30.00K | 1,198,905 |
| Charles Stuart Arnold Director | Jul 26, 2024 | Buy | +25,000 | $0.05 | $1.25K | 1,790,090 |
| Mindshare Holdings, Inc. – | Apr 19, 2024 | Sale | −25,000 | $0.06 | $1.50K | 2,433,399 |
| Darryl V. Green Director | Aug 8, 2023 | Award | +1,254,818 | $0.05 | $62.74K | 3,963,930 |
| Charles Stuart Arnold Director | Jun 12, 2023 | Award | +8,333,333 | $0.05 | $416.67K | 15,474,926 |
| Darryl V. Green Director | Jun 12, 2023 | Award | +2,408,818 | $0.05 | $120.44K | 2,709,112 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 24M shares a day
Change since last report
-99.9%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Stemtech's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,558,688 shares on Sep 17, 2026 over the last 90 days.
See a number that looks wrong?